The distinctive molecular, pathological and clinical characteristics ofBRAF-mutant colorectal tumors-Reference-Cited by-同舟云学术

The distinctive molecular, pathological and clinical characteristics ofBRAF-mutant colorectal tumors

Published:2015-05-15 Issue:8 Volume:15 Page:979-987
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Scartozzi Mario,Giampieri Riccardo,Aprile Giuseppe,Iacono Donatella,Santini Daniele,dell’Aquila Emanuela,Silvestris Nicola,Gnoni Antonio,Bonotto Marta,Puzzoni Marco,Demurtas Laura,Cascinu Stefano

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737159.2015.1047346

Reference86 articles.

1. Mutations of the BRAF gene in human cancer

2. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600E but not KRAS mutations

3. B-Raf Inhibits Programmed Cell Death Downstream of Cytochrome c Release from Mitochondria by Activating the MEK/Erk Pathway

4. Increasing complexity of Ras signaling

5. Ras effectors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study;International Journal of Molecular Sciences;2023-05-22

2. Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice;Frontiers in Oncology;2021-05-10

3. V600E and Non-V600E BRAF Mutations in Colorectal Cancer: Clinicopathologic Correlations in a Single Institution;International Journal of Hematology and Oncology;2021-03-30

4. BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?;Targeted Oncology;2021-02-18

5. Treatment options in BRAF-mutant metastatic colorectal cancer;Anti-Cancer Drugs;2020-07